Parikh, Shamik
AstraZeneca (United States)
2 papers on CoChatORCID 0009-0001-2380-439X
Most cited papers
- Verified
Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin
Bolinder, J., Ljunggren, Ö., Kullberg, J., Johansson, L., Wilding, J., Langkilde, A. M., Sugg, J., & Parikh, S. (2012) · The Journal of Clinical Endocrinology & Metabolism
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 867
- Verified
Dapagliflozin’s effects on glycemia and cardiovascular risk factors in high-risk patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension
Cefalu, W. T., Leiter, L. A., de Bruin, T. W. A., Gause-Nilsson, I., Sugg, J., & Parikh, S. J. (2015) · Diabetes Care
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 182
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free